U.S. market Closed. Opens in 7 hours 42 minutes

HSCS | Heart Test Laboratories, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 2.7300 - 2.9100
52 Week Range 2.3600 - 52.00
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 33,412
Average Volume 361,607
Shares Outstanding 913,321
Market Cap 2,493,366
Sector Healthcare
Industry Medical - Devices
IPO Date 2022-06-16
Valuation
Profitability
Growth
Health
P/E Ratio -0.32
Forward P/E Ratio N/A
EPS -8.41
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 15
Country USA
Website HSCS
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
*Chart delayed
Analyzing fundamentals for HSCS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see HSCS Fundamentals page.

Watching at HSCS technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on HSCS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙